Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence: Moving fast, understanding slowly. Are we leading or just reacting?

Radiography (London, England : 1995)·2026
Same author

Challenges confronting sustainability in nuclear medicine practice.

Radiography (London, England : 1995)·2024
Same author

The potential role of artificial intelligence in sustainability of nuclear medicine.

Radiography (London, England : 1995)·2024
Same author

Editorial: Next Generation Technologists for Next Generation Technology.

Radiography (London, England : 1995)·2023
Same author

Topical sensor metrics for 18F-FDG positron emission tomography dose extravasation.

Radiography (London, England : 1995)·2020
Same author

The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis.

Arthritis research & therapy·2020

Related Experiment Video

Updated: Jun 27, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K

[18F]fluorodeoxyglucose positron emission tomography/computed tomography in combination with clinical data in

P Cegla1, G M Currie2, W Cholewinski3

  • 1Department of Nuclear Medicine, Greater Poland Cancer Centre, Poznań, Poland.

Radiography (London, England : 1995)
|April 25, 2024
PubMed
Summary

Artificial neural networks (ANNs) can predict overall survival in lung cancer patients using [18F]FDG PET/CT parameters. Key predictors include total lesion glycolysis and SUVmax, offering insights for patient follow-up.

Keywords:
Computed tomographyLung cancerNeural networkPositron emission tomographySurvival

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K
Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm
06:53

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

5.6K

Related Experiment Videos

Last Updated: Jun 27, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K
Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm
06:53

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

5.6K

Area of Science:

  • Nuclear medicine imaging
  • Oncology
  • Artificial intelligence in medicine

Background:

  • Positron emission tomography/computed tomography (PET/CT) is crucial for lung cancer evaluation.
  • Predicting overall survival (OS) aids in patient management and follow-up strategies.

Purpose of the Study:

  • To assess the predictive capability of [18F]Fluorodeoxyglucose ([18F]FDG) PET/CT parameters on OS in lung cancer.
  • To compare the predictive power of an artificial neural network (ANN) against conventional statistical analysis.

Main Methods:

  • Retrospective analysis of 165 lung cancer patients.
  • Evaluation of PET/CT parameters including SUVmax, SUVmean, TLG, and MTV for primary and metastatic lesions.
  • Comparison of ANN analysis with conventional statistical methods (Chi-Square, Student's t-test).

Main Results:

  • Males exhibited significantly higher SUVmax, MTV, TLG, TLGtotal, and MTVtotal than females.
  • An optimized ANN model identified TLGtotal, SUVmaxtotal, SUVmeantotal, and disease stage as key predictors of survival.
  • The ANN achieved an AUC of 0.764 with 92.3% sensitivity and 57.1% specificity.

Conclusions:

  • Both conventional statistics and ANN identified similar variables predicting decreased survival.
  • The ANN provides a weighted algorithm for predicting decreased survival based on key PET/CT features.
  • These predictive parameters can help identify patients requiring closer monitoring.